Tag: Blood Disorders
Negative D-Dimer Can Safely Rule Out DVT as Standalone Test
Standalone D-dimer testing followed by whole-leg compression US in positive patients rules out DVT
ACS: Tranexamic Acid No Better Than Placebo After Severe Injury
Antifibrinolytic agent may lower 30-day mortality when used within one hour of injury, for severe shock
Individuals With Blood Group O Have Lower Risk for COVID-19
And more COVID-19 patients with blood group A or AB require mechanical ventilation, CRRT
Antibodies Decrease With Time After COVID-19 Symptom Onset
For all donors of convalescent plasma, drop seen in anti-RBD antibody levels from first to last donation
Red Blood Cell Distribution Width, Mortality Tied in COVID-19
Elevated RDW and increase in RDW during hospitalization linked to increased mortality risk
No Proof Convalescent Plasma Effective Against COVID-19
NIH panel says data are insufficient to recommend either for or against the use of convalescent plasma
WHO: Plasma Therapy for COVID-19 Still Experimental
FDA 'emergency use authorization' does not mean plasma therapy has been proven safe and effective
FDA Approves Wider Use of Plasma as COVID-19 Treatment
President Donald Trump announced emergency approval as 'breakthrough' treatment during a news briefing Sunday
FDA Emergency Approval on Hold for Blood Plasma to Treat COVID-19
More data are under review; the approval could still be issued in the near future
Convalescent Plasma Efficacious for Severe COVID-19
Significant reduction seen in mortality, specifically among patients transfused with plasma within 72 hours
